Introduction
This session provides a practical, imaging-focused overview of breast reduction and augmentation procedures. It covers operative techniques, expected post-operative appearances across modalities, common complications, and key imaging signs that guide diagnosis and follow-up. Emphasis is placed on mammography, ultrasound, and MRI interpretation in patients with reductions, mastopexy, and a range of implant types and positions, including recognition of benign postoperative changes versus findings that warrant closer surveillance or intervention.
Breast Reduction Surgery: Indications and Operative Techniques
Breast reduction (reduction mammaplasty) is performed for symptomatic macromastia (back/neck pain, postural changes), and for symmetry after mastectomy. Multiple incision patterns are used to remove inferior parenchyma and elevate the nipple-areolar complex (NAC).
Key Points
- Wise pattern (keyhole/anchor): periareolar, vertical to inframammary fold (IMF), plus transverse IMF incision; most common.
- Vertical (lollipop): periareolar plus vertical limb only; no IMF transverse scar.
- Transverse reduction: transverse IMF incision with periareolar adjustment; no vertical limb.
- Goal: inferior tissue resection and superior/central repositioning of NAC.
Post-Reduction Mammographic Appearances
Healing is variable; some patients exhibit minimal change while others show classic scar patterns. Recognizing characteristic post-surgical features prevents unnecessary callbacks.
Key Points
- MLO: inferior parenchymal “swirling” or arc-like redistribution from tissue elevation.
- CC: linear fibrous scar extending nipple-to-pectoralis and/or medial–lateral line along the IMF plane.
- Periareolar scar: circumferential or partial ring density around NAC; may contain benign calcifications.
- NAC position: may appear superiorly displaced postoperatively.
- Keloids: thick, rope-like cutaneous scars may be visible.
Post-Reduction Sequelae and Management
Benign post-surgical changes overlap those seen after other breast operations. Awareness of typical timing and stability aids management.
Key Points
- Fat necrosis: oil cysts, coarse dystrophic calcifications at surgical site; often benign when correlated with history.
- Architectural distortion: focal dense scar with straightening/traction lines.
- Asymmetry and displaced “islands” of parenchyma: focal tissue that appears out of normal ductal flow; assess stability over time.
- Fluid collections: hematoma/seroma may present as evolving masses or mixed echotexture.
- Follow-up: if uncertain early post-op, 6-month short-interval follow-up to confirm stability or resolution; resume annual screening when classic changes are present without concerning features.
Liposuction Reduction and Mastopexy: Techniques and Imaging
Liposuction can be used alone or adjunctively for contouring; ultrasound-assisted liposuction liquefies fat before aspiration. Mastopexy (breast lift) removes redundant skin (often post-pregnancy/weight change) with minimal effect on parenchyma; implants may be added.
Key Points
- Liposuction: can yield dramatic density changes and mixed echogenic masses; hematoma and scarring may mimic pathology.
- Mastopexy patterns: keyhole/vertical or periareolar “donut” excisions; primarily skin resection and NAC repositioning.
- Imaging: mastopexy often shows minimal parenchymal change; may see periareolar scar/fat necrosis.
Breast Augmentation: Historical Context and Epidemiology
Augmentation methods evolved from early injections/solid materials to modern implants. Today, augmentation and post-mastectomy reconstruction are common in the U.S., with regional variability in prevalence.
Key Points
- Early methods (paraffin, sponge, ivory, beeswax, liquid silicone injections) had high complication rates; modern implants began in the 1960s (saline in 1962; silicone gel in 1963).
- Millions of U.S. women have implants; cosmetic and reconstructive indications account for annual growth.
Regulatory Status and Safety Considerations
Regulatory approvals and safety data inform candidacy and surveillance.
Key Points
- FDA: silicone gel approved for augmentation ≥22 years; saline ≥18 years; both permitted at any age for reconstruction; silicone injections banned (1992).
- Systemic disease: large reviews show no association between silicone implants and connective tissue or neurologic disease.
- Anaplastic large cell lymphoma (ALCL): rare implant-associated cases occur in peri-implant fluid/capsule; can present years post-implantation.
- Psychosocial: studies show increased suicide risk; causality unclear (selection vs implant effect).
- Local complications: pain, parenchymal atrophy (with large implants), capsular contracture, malposition/asymmetry, hematoma/infection, skin/NAC necrosis, rupture.
Implant Anatomy and Materials
Understanding implant structure is foundational for imaging interpretation.
Key Points
- Envelope: manufacturer’s outer shell containing implant filler.
- Capsule: host-derived fibrous tissue encasing the implant; thickness varies.
- Silicone gel: modern “gummy bear” cohesive gels are firmer, designed to limit leakage.
- Saline: physiologic saline; valve used for intraoperative fill.
Implant Types and Their Imaging Appearance
Implant filler and construction influence modality-specific appearances.
Key Points
- Single-lumen silicone: mammography shows dense, circumscribed ovoid; MRI shows bright silicone on silicone-specific sequences.
- Single-lumen saline: often radiolucent on mammography; visible fill valve/folds may confirm saline; MRI T2 bright like water; valve indentation may be seen.
- Double-lumen (silicone core, saline shell): less common; designed to sequester silicone if inner envelope fails.
- Stacked implants: two devices layered to achieve volume/shape; dark interface line on MRI/US corresponds to adjacent envelopes.
Implant Positioning and Incisions
Position affects cosmetic results and imaging coverage; incision choice varies by surgeon and indication.
Key Points
- Subglandular: most natural appearance; obscures more parenchyma on mammography.
- Subpectoral (retromuscular): improves mammographic visualization; risk of pectoralis atrophy with large devices.
- Determining position: on MLO, subpectoral shows pectoralis fibers overlying part of the implant; subglandular shows pec entirely posterior.
- Incisions: inframammary fold (common), periareolar, transaxillary, and occasionally periumbilical approaches.
Mammography with Implants: Protocols and Limitations
Optimized technique is essential; even so, parenchymal coverage remains limited, especially with subglandular placement.
Key Points
- Views: obtain standard CC/MLO plus implant-displaced (ID) views to maximize tissue visualization.
- Technique: during ID views, push implant posteriorly and pull breast tissue forward; ensure AEC/detector targets breast tissue not the implant (avoid underexposure).
- Additional views: consider a 90-degree lateral for tissue coverage if needed.
- Reporting: note limited evaluation due to implant, particularly with subglandular placement; document implant malposition or contour abnormalities.
Ultrasound of Implants: Normal Appearances and Tips
Ultrasound complements mammography for focal symptoms and implant assessment, though silicone vs saline often looks similar.
Key Points
- Normal: echogenic parallel lines for capsule/envelope; anechoic to hypoechoic filler with reverberation artifact; saline valve may be palpable/visible.
- Troubleshooting: identify the implant margin and follow it to ambiguous areas to differentiate folds from pathology.
- Newer devices: multilayer envelopes can create multiple closely apposed lines—normal finding.
MRI of Implants: Protocol and Normal Findings
MRI is the preferred modality for silicone implant integrity assessment using silicone-sensitive sequences.
Key Points
- Technique: STIR with both fat and water saturation renders silicone bright and suppresses other tissues; T1/T2-weighted sequences provide adjunctive information.
- Normal: bright silicone with smooth contour; thin dark capsule margin; parenchyma largely suppressed on silicone-specific sequences.
Normal Variants vs Pathology: Radial Folds and Infolding
Recognizing benign folds prevents overcalling rupture.
Key Points
- Radial fold: thin dark line that connects to the implant surface; no silicone within the fold; seen on MRI and US.
- Edge infolding/crenulation: subtle scalloping of contour in softer implants; benign.
- If uncertainty persists on US, MRI can adjudicate.
Capsular Calcification and Implant Herniation
Chronic capsular reactions and focal bulges have characteristic appearances and implications.
Key Points
- Capsular calcifications: coarse dystrophic calcifications just anterior to the implant; more concerning in older silicone devices; consider documenting for surgical discussion.
- Herniation: smooth focal outpouching through a capsular defect with intact envelope; seen on mammography, US (subtle contour bulge), or MRI (tail-like protrusions).
Implant Rupture: Saline vs Silicone—Clinical and Imaging
Rupture mechanisms include device aging, fold fatigue, surgical/traumatic injury; risk increases with implant age.
Key Points
- Saline rupture: clinically obvious deflation as saline is resorbed; imaging typically unnecessary unless documenting collapsed shell.
- Silicone rupture: often clinically silent; mean lifespan ~13 years (augmentation) and ~9–10 years (reconstruction); rupture rates rise markedly after ~10 years.
Intracapsular Silicone Rupture: Imaging Signs
The envelope fails but the fibrous capsule remains intact; most common rupture pattern.
Key Points
- Mammography: limited for detection; contour often unchanged.
- Ultrasound: stepladder sign—multiple parallel echogenic lines from folded envelope; distinguish from benign radial folds.
- MRI:
- Keyhole/teardrop sign: fold containing silicone on both sides (silicone bright internally and externally).
- Linguine sign: multiple curvilinear dark lines (collapsed envelope) floating in bright silicone.
- Increased intraluminal water (dark foci on water-suppressed sequences), especially in double-lumen devices.
Extracapsular Silicone Rupture: Imaging Signs
Both envelope and capsule fail; free silicone escapes into surrounding tissues and nodes.
Key Points
- Clinical: pain, shape change, contracture, asymmetry; exam detects a subset.
- Mammography: dense, shaggy free silicone in parenchyma/pectoralis; irregular peri-implant densities; highly calcified, distorted implants may coexist.
- Ultrasound: snowstorm sign—highly echogenic foci with marked posterior shadowing; silicone “cysts” (more liquid components); echogenic granulomas; hyperechoic lymph nodes.
- MRI: silicone signal outside the capsule; loss of expected envelope/capsule contours; regional silicone tracking into breast or muscle.
Reporting Pearls and Patient Counseling Considerations
Clear communication improves patient management and expectations.
Key Points
- State implant type/position when determinable; comment on technical limitations and tissue coverage.
- Describe classic post-reduction or mastopexy changes to avoid unnecessary workup; use short-interval follow-up when uncertainty exists early post-op.
- Document capsular calcifications, herniations, malposition, or suspected rupture; recommend MRI for silicone integrity when indicated.
- Correlate palpable “lumps” over valves or scars with benign implant-related findings when appropriate.
Conclusion
Breast reduction and augmentation produce a spectrum of predictable postoperative findings and device-related complications. Proficient interpretation across mammography, ultrasound, and MRI hinges on understanding surgical techniques, implant construction and position, and hallmark imaging signs such as periareolar scarring, radial folds, stepladder, keyhole/teardrop, linguine, and snowstorm patterns. Consistent technique, precise reporting, and judicious follow-up help differentiate benign postoperative changes from pathology, guide appropriate management, and set realistic expectations for patients with reduced or augmented breasts.
